|
Nattō
is produced by a fermentation process
by adding Bacillus Nattō, a beneficial bacterium, to boiled
soybeans. The resulting Nattokinase enzyme, is produced when Bacillus
Nattō acts on the soybeans. The enzyme is then purified and isolated
into tablet form. Unlike aspirin and most other anticoagulant drugs
which interfere with fibrin production, Nattokinase acts directly on
the fibrin that binds platelets and red blood cells to form clots. It
has the ability to dissolve fibrin thus releasing platelets and
unclotting areas of unnecessary blood flow restriction. By enhancing
the body’s own production of plasmin, Nattokinase also acts as a
coagulation preventative.
Nattokinase
also supports blood clearing by breaking down Plasminogen Activator –
Inhibitor – 1(PAI-1). PAI-1 restricts the activity of plasmin
within the body (Prevent Heart Attack and Stroke with Potent Enzyme
that Dissolves Deadly Blood Clots in Hours. Health Sciences
Institute, March 2002).
|
